Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Here are top 10 stocks to focus on January 13 - Cairn India, Jet Airways, Apollo Tyres, Ceat, Crompton Greaves, Bank Nifty, Hindalco, CMC, Clariant Chemicals and Spicejet. We are also watching Dr Reddy's, Sun Pharma, Ipca Labs, Lupin, Cipla, ACC and Ultratech.
Krish Subramanyam of Asit C Mehta Investment Intermediates recommends buying Dr Reddy's Laboratories 3200 Put and sell 3000 Put.
Here are top 10 stocks to focus on January 1 - HPCL, Maruti, ICICI Bank, Axis Bank, Dr Reddy's, HCL Tech, Bharti Airtel, Marico, Adani Ports & Rallis India.
According to Sudarshan Sukhani of s2analytics.com, one may prefer Dr Reddy's Laboratories.
Andrew Holland of Ambit Investment is of the view that one may avoid IT, pharma and consumer space.
Phani Sekhar of Angel Broking is of the view that one may pick Dr Reddy's Laboratories.
Sudarshan Sukhani of s2analytics.com is of the view that one may avoid Dr Reddy's Laboratories.
Sudarshan Sukhani of s2analytics.com advises buying Dr Reddy‘s Laboratories.
Sudarshan Sukhani of s2analytics.com is of the view that one may prefer Asian Paints for long term.
Here are top 10 stocks to keep an eye on December 17 - Infosys, Zee Entertainment, Tata Steel, Dr Reddy's, Jagran Prakashan, Reliance Capital, Bharti Airtel, UPL, HCL Tech and TCS.
Here are top 10 stocks to focus on December 15 – Mahindra and Mahindra (M&M), HCL Technologies, India Cement, Gas Authority of India (GAIL), Tata Consultancy Services (TCS), Bank Nifty, Dr Reddy's, Glenmark, Havells and SpiceJet.
Sudarshan Sukhani of s2analytics.com recommends booking profits in Alembic and advises switching to Sun Pharma or Dr Reddy's Labs.
Here are top 10 stocks to focus on December 4 - Ashok Leyland, Apollo Tyres, NBCC, HDFC Bank, ICICI Bank, MBL Infra, SAIL, Ranbaxy, Dr Reddy's and Sadbhav Engineering.
According to Nitin Agrawal - Pharma Analyst at IDFC Securities, Sun Pharma, Lupin and Dr Reddy's labs are the preferred picks.
Sudarshan Sukhani of s2analytics.com recommends buying Dr Reddy's Laboratories and Aurobindo Pharma.
VK Sharma of HDFC Securities recommends buying Dr Reddy's Laboratories 3500 Call.
For the largecap pharma companies the game has become completely US-cued. So, US will be the driver for Dr Reddys and Lupin, says Anmol Ganjoo.
Surajit Pal, pharma analyst, Prabhudas Lilladher, expects Teva, Mylan, Sandoz and Dr Reddy‘s Laboratories to benefit from this loss.
Mayuresh Joshi, VP- Institution at Angel Broking is of the view that YES Bank, LIC Housing Finance and Infosys are attractive bets.
Sudarshan Sukhani of s2analytics.com recommends buying Bharat Forge, Larsen and Toubro and Dr Reddy's Laboratories.
Yogesh Mehta of Motilal Oswal recommends buying State Bank of India and Dr Reddy's Laboratories.
Phani Sekhar of Angel Broking recommends accumulating Dr Reddy's Laboratories for long term.
According to Sudarshan Sukhani of s2analytics.com, one may buy Dr Reddys Laboratories and Glenmark Pharma.
Manas Jaiswal of manasjaiswal.com recommends buying IRB Infra with a target of Rs 254 and NHPC with a target of Rs 21.
Krish Subramanyam of Asit C Mehta Inv Intermediates recommends bull spread in Dr Reddy's Laboratories wherein one can buy 3000 call and sell 3200 call.